Spire Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $662K | Sell |
1,632
-297
| -15% | -$120K | 0.02% | 452 |
|
|
2025
Q1 | $960K | Buy |
1,929
+379
| +24% | +$189K | 0.03% | 409 |
|
|
2024
Q4 | $806K | Buy |
1,550
+65
| +4% | +$33.8K | 0.03% | 439 |
|
|
2024
Q3 | $919K | Buy |
1,485
+1
| +0.1% | +$619 | 0.03% | 389 |
|
|
2024
Q2 | $820K | Sell |
1,484
-285
| -16% | -$158K | 0.03% | 383 |
|
|
2024
Q1 | $1.03M | Buy |
1,769
+98
| +6% | +$57K | 0.02% | 369 |
|
|
2023
Q4 | $922K | Sell |
1,671
-343
| -17% | -$189K | 0.03% | 382 |
|
|
2023
Q3 | $1.02M | Sell |
2,014
-660
| -25% | -$334K | 0.04% | 320 |
|
|
2023
Q2 | $1.4M | Sell |
2,674
-154
| -5% | -$80.4K | 0.05% | 282 |
|
|
2023
Q1 | $1.63M | Buy |
2,828
+648
| +30% | +$373K | 0.06% | 253 |
|
|
2022
Q4 | $1.2M | Sell |
2,180
-64
| -3% | -$35.2K | 0.07% | 213 |
|
|
2022
Q3 | $1.14M | Sell |
2,244
-751
| -25% | -$381K | 0.07% | 195 |
|
|
2022
Q2 | $1.63M | Sell |
2,995
-1,250
| -29% | -$679K | 0.07% | 237 |
|
|
2022
Q1 | $2.51M | Sell |
4,245
-86
| -2% | -$50.8K | 0.07% | 238 |
|
|
2021
Q4 | $2.89M | Buy |
4,331
+30
| +0.7% | +$20K | 0.06% | 255 |
|
|
2021
Q3 | $2.46M | Buy |
4,301
+18
| +0.4% | +$10.3K | 0.07% | 250 |
|
|
2021
Q2 | $2.16M | Sell |
4,283
-19
| -0.4% | -$9.57K | 0.06% | 277 |
|
|
2021
Q1 | $1.96M | Buy |
+4,302
| New | +$1.96M | 0.05% | 286 |
|